Health State Utility Assessment for Breast Cancer

Vivianne Shih, Alexandre Chan, Feng Xie, Yu Ko

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives: 1) To develop both English and Chinese versions of the descriptions of health states describing different stages of breast cancer and different adverse effects related to tamoxifen and aromatase inhibitors for breast cancer and 2) to elicit individuals' preferences for these health states from a group of oncology nurses. Methods:Twenty hypothetical health states and their descriptions were developed on the basis of literature review and oncology expert panel reviews. Health state utilities were obtained from 20 oncology nurses by using the visual analogue scale and standard gamble methods. After recalibration, the adjusted utility scores were on a scale of 0 (dead) and 1 (perfect health).Results:The health states developed represented different disease stages and the presence and type of treatment side effects in breast cancer. For each health state, various general health-related quality-of-life domains, such as pain/discomfort and ability to work, were included in the descriptions, along with a state-specific description. The mean utility score of respondents' "current health" was greater than 0.9, while mean adjusted visual analogue scale-derived utility scores ranged from 0.256 to 0.860 and median adjusted standard gamble-derived utility scores ranged from 0.284 to 0.673. Among the side effects evaluated in the "no recurrence" health state, ischemic cerebrovascular events, pulmonary embolism, and spine fracture had the greatest utility detriment. Conclusions:The study results indicate the value that individuals place on the avoidance of disease progression and the side effects of hormonal therapies in breast cancer. The health state descriptions developed can be used in future research to obtain society's utilities for use in a cost-utility analysis.

Original languageEnglish
Pages (from-to)93-97
Number of pages5
JournalValue in Health Regional Issues
Volume1
Issue number1
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Breast Neoplasms
Health
Visual Analog Scale
Nurses
Breast cancer
Utility assessment
Health state
Aromatase Inhibitors
Aptitude
Tamoxifen
Pulmonary Embolism
Cost-Benefit Analysis
Disease Progression
Spine
Quality of Life
Recurrence
Pain
Oncology
Side effects
Therapeutics

Keywords

  • Breast cancer
  • Standard gamble
  • Utility
  • VAS

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Economics, Econometrics and Finance (miscellaneous)

Cite this

Health State Utility Assessment for Breast Cancer. / Shih, Vivianne; Chan, Alexandre; Xie, Feng; Ko, Yu.

In: Value in Health Regional Issues, Vol. 1, No. 1, 2012, p. 93-97.

Research output: Contribution to journalArticle

Shih, Vivianne ; Chan, Alexandre ; Xie, Feng ; Ko, Yu. / Health State Utility Assessment for Breast Cancer. In: Value in Health Regional Issues. 2012 ; Vol. 1, No. 1. pp. 93-97.
@article{dde3c23da7404a71886d43b7bd15b03f,
title = "Health State Utility Assessment for Breast Cancer",
abstract = "Objectives: 1) To develop both English and Chinese versions of the descriptions of health states describing different stages of breast cancer and different adverse effects related to tamoxifen and aromatase inhibitors for breast cancer and 2) to elicit individuals' preferences for these health states from a group of oncology nurses. Methods:Twenty hypothetical health states and their descriptions were developed on the basis of literature review and oncology expert panel reviews. Health state utilities were obtained from 20 oncology nurses by using the visual analogue scale and standard gamble methods. After recalibration, the adjusted utility scores were on a scale of 0 (dead) and 1 (perfect health).Results:The health states developed represented different disease stages and the presence and type of treatment side effects in breast cancer. For each health state, various general health-related quality-of-life domains, such as pain/discomfort and ability to work, were included in the descriptions, along with a state-specific description. The mean utility score of respondents' {"}current health{"} was greater than 0.9, while mean adjusted visual analogue scale-derived utility scores ranged from 0.256 to 0.860 and median adjusted standard gamble-derived utility scores ranged from 0.284 to 0.673. Among the side effects evaluated in the {"}no recurrence{"} health state, ischemic cerebrovascular events, pulmonary embolism, and spine fracture had the greatest utility detriment. Conclusions:The study results indicate the value that individuals place on the avoidance of disease progression and the side effects of hormonal therapies in breast cancer. The health state descriptions developed can be used in future research to obtain society's utilities for use in a cost-utility analysis.",
keywords = "Breast cancer, Standard gamble, Utility, VAS",
author = "Vivianne Shih and Alexandre Chan and Feng Xie and Yu Ko",
year = "2012",
doi = "10.1016/j.vhri.2012.03.009",
language = "English",
volume = "1",
pages = "93--97",
journal = "Value in Health Regional Issues",
issn = "2212-1099",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Health State Utility Assessment for Breast Cancer

AU - Shih, Vivianne

AU - Chan, Alexandre

AU - Xie, Feng

AU - Ko, Yu

PY - 2012

Y1 - 2012

N2 - Objectives: 1) To develop both English and Chinese versions of the descriptions of health states describing different stages of breast cancer and different adverse effects related to tamoxifen and aromatase inhibitors for breast cancer and 2) to elicit individuals' preferences for these health states from a group of oncology nurses. Methods:Twenty hypothetical health states and their descriptions were developed on the basis of literature review and oncology expert panel reviews. Health state utilities were obtained from 20 oncology nurses by using the visual analogue scale and standard gamble methods. After recalibration, the adjusted utility scores were on a scale of 0 (dead) and 1 (perfect health).Results:The health states developed represented different disease stages and the presence and type of treatment side effects in breast cancer. For each health state, various general health-related quality-of-life domains, such as pain/discomfort and ability to work, were included in the descriptions, along with a state-specific description. The mean utility score of respondents' "current health" was greater than 0.9, while mean adjusted visual analogue scale-derived utility scores ranged from 0.256 to 0.860 and median adjusted standard gamble-derived utility scores ranged from 0.284 to 0.673. Among the side effects evaluated in the "no recurrence" health state, ischemic cerebrovascular events, pulmonary embolism, and spine fracture had the greatest utility detriment. Conclusions:The study results indicate the value that individuals place on the avoidance of disease progression and the side effects of hormonal therapies in breast cancer. The health state descriptions developed can be used in future research to obtain society's utilities for use in a cost-utility analysis.

AB - Objectives: 1) To develop both English and Chinese versions of the descriptions of health states describing different stages of breast cancer and different adverse effects related to tamoxifen and aromatase inhibitors for breast cancer and 2) to elicit individuals' preferences for these health states from a group of oncology nurses. Methods:Twenty hypothetical health states and their descriptions were developed on the basis of literature review and oncology expert panel reviews. Health state utilities were obtained from 20 oncology nurses by using the visual analogue scale and standard gamble methods. After recalibration, the adjusted utility scores were on a scale of 0 (dead) and 1 (perfect health).Results:The health states developed represented different disease stages and the presence and type of treatment side effects in breast cancer. For each health state, various general health-related quality-of-life domains, such as pain/discomfort and ability to work, were included in the descriptions, along with a state-specific description. The mean utility score of respondents' "current health" was greater than 0.9, while mean adjusted visual analogue scale-derived utility scores ranged from 0.256 to 0.860 and median adjusted standard gamble-derived utility scores ranged from 0.284 to 0.673. Among the side effects evaluated in the "no recurrence" health state, ischemic cerebrovascular events, pulmonary embolism, and spine fracture had the greatest utility detriment. Conclusions:The study results indicate the value that individuals place on the avoidance of disease progression and the side effects of hormonal therapies in breast cancer. The health state descriptions developed can be used in future research to obtain society's utilities for use in a cost-utility analysis.

KW - Breast cancer

KW - Standard gamble

KW - Utility

KW - VAS

UR - http://www.scopus.com/inward/record.url?scp=84984585584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984585584&partnerID=8YFLogxK

U2 - 10.1016/j.vhri.2012.03.009

DO - 10.1016/j.vhri.2012.03.009

M3 - Article

AN - SCOPUS:84984585584

VL - 1

SP - 93

EP - 97

JO - Value in Health Regional Issues

JF - Value in Health Regional Issues

SN - 2212-1099

IS - 1

ER -